Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - calcium chloride dihydrate, quantity: 36 micromole/ml; human thrombin, quantity: 400 iu/ml - solution - excipient ingredients: albumin; sodium chloride; water for injections - tissel is indicated: - as adjunct to haemostasis during surgical procedures, when control of bleeding by conventional surgical techniques is ineffective or impractical; and - as a sealant as an adjunct for closure of colostomies. - as a sealant and/or adhesive for use in autologous chrondrocyte implantation (aci) or matrix-induced autologous chondrocyte implantation (maci) procedures. - for mesh fixation in non-iatrogenic abdominal wall hernia repair, as an alternative to sutures, staples or tacks.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 28.09 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; triacetin - revatio is used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of revatio has not been evaluated in patients currently on bosentan therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; croscarmellose sodium; calcium hydrogen phosphate; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; hypromellose; calcium hydrogen phosphate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 140.45 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; vanillin; biotin - viagra is indicated for the treatment of erectile dysfunction in adult males. viagra is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 70.23 mg (equivalent: sildenafil, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; vanillin; biotin - viagra is indicated for the treatment of erectile dysfunction in adult males. viagra is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 35.11 mg (equivalent: sildenafil, qty 25 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; vanillin; biotin - viagra is indicated for the treatment of erectile dysfunction in adult males. viagra is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - sildenafil citrate, quantity: 140.48 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; croscarmellose sodium; colloidal anhydrous silica; hypromellose; indigo carmine aluminium lake; lactose monohydrate; titanium dioxide; triacetin - sildenafil lupin is indicated for the treatment of erectile dysfunction in adult males. sildenafil lupin is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; hypromellose; indigo carmine aluminium lake; lactose monohydrate; titanium dioxide; triacetin - sildenafil lupin is indicated for the treatment of erectile dysfunction in adult males. sildenafil lupin is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd - botulinum toxin - type a; botulinum toxin, type a; botulinum toxin, type a -